NCT04013477View on ClinicalTrials.gov

Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

December 5, 2019

Study Completion Date

April 6, 2020

Conditions
Healthy
Interventions
DRUG

DA-5207

DA-5207 Transdermal Delivery System

DRUG

Donepezil Hydrochloride

donepezil HCl 10mg QD

Trial Locations (1)

03722

Clinical Trials Center, Severance Hospital, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT04013477 - Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults | Biotech Hunter | Biotech Hunter